NCT04567212 is a clinical trial of genetic evaluation in Allergic Asthma, sponsored by University of Catanzaro.

Who is sponsoring NCT04567212?

NCT04567212 is sponsored by University of Catanzaro.

What drugs are being tested in NCT04567212?

Interventions in NCT04567212: genetic evaluation, MicroRNA evaluation.

What condition does NCT04567212 study?

NCT04567212 studies Allergic Asthma, Asthma.

Is NCT04567212 still recruiting?

NCT04567212 is currently status unknown. Last updated 23 November 2020.

Last reviewed 2020-11-23 · How we verify

NCT04567212

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gender Differences and SNPs in Asthmatic Patients

Status unknown Last updated 23 November 2020

What this trial tests

trial testing genetic evaluation in Allergic Asthma in 50 participants. Status unknown.

Timeline

1 August 2020

Primary endpoint
20 November 2021

30 December 2021

Quick facts

Lead sponsor	University of Catanzaro
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 August 2020
Primary completion	20 November 2021
Estimated completion	30 December 2021
Sites	2 locations across Italy

Drugs / interventions tested

genetic evaluation
MicroRNA evaluation

Conditions studied

Allergic Asthma — all drugs for Allergic Asthma →
Asthma — all drugs for Asthma →

Sponsor

University of Catanzaro

Who can join

Adults 6 to 75, any sex, with Allergic Asthma or Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The GINA 2020 guidelines suggest that asthma affects approximately 300 million persons worldwide. Even if there is a specific drug treatment for each stage of disease (From mild to severe) in some patients it is not efficacy and it culd be reated to the gender difference Polymorphisms seems to be involved in asthma (allergic or not) even if no data have been published concerning the role of gender in this clinical manifestation. The aim of this study is to assess whether genetic variations involved in the genes encoding the two key leukotriene enzymes, ALOX5 and LTC4S, and CysLTR1 are implicated in the sex difference of allergic asthma in a well-characterized patient cohort.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Circulating MicroRNAs Expression Profile in Lung Inflammation: A Preliminary Study.
Mirra D, Cione E, Spaziano G, Esposito R, et al · · 2022 · cited 22× · PMID 36143090 · DOI 10.3390/jcm11185446
Association between Sex-Related <i>ALOX5</i> Gene Polymorphisms and Lung Atopy Risk.
Mirra D, Esposito R, Spaziano G, Rafaniello C, et al · · 2023 · cited 5× · PMID 37109111 · DOI 10.3390/jcm12082775

Verify or expand the search:

Other recruiting trials for Allergic Asthma

Currently open trials in the same condition.

NCT07055542 — Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study · NA · recruiting
NCT06960382 — Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Ast · Phase 1, PHASE2 · recruiting
NCT07342803 — Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients · Phase 2 · recruiting
NCT06438757 — Trial of JYB1904 in Patients With Allergic Asthma · Phase 2 · active not recruiting
NCT06771934 — Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma · active not recruiting

Other University of Catanzaro trials

Trials by the same sponsor.

NCT06844552 — Diamagnetic Therapy in Pain and Inflammation · recruiting
NCT07508969 — Proprioceptive Neuromuscular Facilitation vs Conventional Therapy With Ultrasound-Guided Corticosteroid Injections for S · Phase 1, PHASE2 · completed
NCT07504432 — Efficacy of Oxygen-ozone Therapy and Cervical Rehabilitation · Phase 1, PHASE2 · completed
NCT06814769 — Hyaluronic Acid and Articular Pain · completed
NCT05134597 — Gene Expression in Chronic Venous Leg Ulcers · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04567212 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Catanzaro
Last refreshed: 23 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04567212.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing